• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Sep30
Distribution Plan(EST)

Cash dividend 0.59 USD

Aug23
Distribution Plan(EST)

Cash dividend 0.59 USD

Distribution Plan(EST)

Cash dividend 0.59 USD

View More

Event Tracking

Dec26
Tianfeng Securities releases a research report analyzing the weight-loss market and noting Eli Lilly's competitive advantage
13:50
Eli Lilly Pays ABL Bio $55 Million as a Prepayment
10:18
ABL Bio and Eli Lilly Enter into $40 Million Prepayment and Long-term Collaboration Agreement
04:40
Eli Lilly to Participate in the 44th Annual J.P. Morgan Healthcare Conference
02:20
Analysts view Eli Lilly as a top stock split candidate for 2026 due to its leading position in the weight-loss drug market.
00:00
An Eli Lilly India executive stated that India is entering a transformative phase in obesity care, driven by rising demand and greater access to therapies.
00:00